Cargando…

Incidence, Outcomes and Risk Factors of Heparin-Induced Thrombocytopenia After Total Joint Arthroplasty: A National Inpatient Sample Database Study

Backgrounds: Heparin-induced thrombocytopenia (HIT) is a severe immune-mediated complication of heparin exposure, leading to negative consequences after total hip (THA) and knee arthroplasty (TKA). Materials and Methods: A retrospective study was conducted using the National Inpatient Sample (NIS) d...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuhang, Wang, Jian, Shi, Zhan-jun, Zhang, Yang, Yang, Qinfeng, Xu, Yichuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495517/
https://www.ncbi.nlm.nih.gov/pubmed/34558329
http://dx.doi.org/10.1177/10760296211042938
_version_ 1784579570495651840
author Chen, Yuhang
Wang, Jian
Shi, Zhan-jun
Zhang, Yang
Yang, Qinfeng
Xu, Yichuan
author_facet Chen, Yuhang
Wang, Jian
Shi, Zhan-jun
Zhang, Yang
Yang, Qinfeng
Xu, Yichuan
author_sort Chen, Yuhang
collection PubMed
description Backgrounds: Heparin-induced thrombocytopenia (HIT) is a severe immune-mediated complication of heparin exposure, leading to negative consequences after total hip (THA) and knee arthroplasty (TKA). Materials and Methods: A retrospective study was conducted using the National Inpatient Sample (NIS) database from 2005 to 2014. The incidence and outcomes of HIT after THA or TKA were documented. Logistic regression analysis was performed to identify the postoperative HIT risk factors. Results: A total of 59 3045 patients who underwent THA and 1228 707 patients who underwent TKA were identified. The cumulative incidences were 0.02% and 0.01%, respectively. The HIT group presented significantly higher Charlson Comorbidity Index and Elixhauser Comorbidity Index scores, longer hospital stays (LOS), and higher medical costs. HIT led to a significantly higher mortality rate after THA (2.17% vs 0.16%, P = .0091). In THA, the HIT risk factors were racial minority, AIDS, pulmonary circulation disorders (PCD), psychoses, and hypertension. In TKA, the HIT risk factors were racial minority, PCD, and weight loss. Conclusion: The incidence of HIT after THA and TKA is relatively low; however, HIT significantly increases inpatient mortality, LOS, and medical cost.
format Online
Article
Text
id pubmed-8495517
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-84955172021-10-08 Incidence, Outcomes and Risk Factors of Heparin-Induced Thrombocytopenia After Total Joint Arthroplasty: A National Inpatient Sample Database Study Chen, Yuhang Wang, Jian Shi, Zhan-jun Zhang, Yang Yang, Qinfeng Xu, Yichuan Clin Appl Thromb Hemost Original Manuscript Backgrounds: Heparin-induced thrombocytopenia (HIT) is a severe immune-mediated complication of heparin exposure, leading to negative consequences after total hip (THA) and knee arthroplasty (TKA). Materials and Methods: A retrospective study was conducted using the National Inpatient Sample (NIS) database from 2005 to 2014. The incidence and outcomes of HIT after THA or TKA were documented. Logistic regression analysis was performed to identify the postoperative HIT risk factors. Results: A total of 59 3045 patients who underwent THA and 1228 707 patients who underwent TKA were identified. The cumulative incidences were 0.02% and 0.01%, respectively. The HIT group presented significantly higher Charlson Comorbidity Index and Elixhauser Comorbidity Index scores, longer hospital stays (LOS), and higher medical costs. HIT led to a significantly higher mortality rate after THA (2.17% vs 0.16%, P = .0091). In THA, the HIT risk factors were racial minority, AIDS, pulmonary circulation disorders (PCD), psychoses, and hypertension. In TKA, the HIT risk factors were racial minority, PCD, and weight loss. Conclusion: The incidence of HIT after THA and TKA is relatively low; however, HIT significantly increases inpatient mortality, LOS, and medical cost. SAGE Publications 2021-09-24 /pmc/articles/PMC8495517/ /pubmed/34558329 http://dx.doi.org/10.1177/10760296211042938 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Manuscript
Chen, Yuhang
Wang, Jian
Shi, Zhan-jun
Zhang, Yang
Yang, Qinfeng
Xu, Yichuan
Incidence, Outcomes and Risk Factors of Heparin-Induced Thrombocytopenia After Total Joint Arthroplasty: A National Inpatient Sample Database Study
title Incidence, Outcomes and Risk Factors of Heparin-Induced Thrombocytopenia After Total Joint Arthroplasty: A National Inpatient Sample Database Study
title_full Incidence, Outcomes and Risk Factors of Heparin-Induced Thrombocytopenia After Total Joint Arthroplasty: A National Inpatient Sample Database Study
title_fullStr Incidence, Outcomes and Risk Factors of Heparin-Induced Thrombocytopenia After Total Joint Arthroplasty: A National Inpatient Sample Database Study
title_full_unstemmed Incidence, Outcomes and Risk Factors of Heparin-Induced Thrombocytopenia After Total Joint Arthroplasty: A National Inpatient Sample Database Study
title_short Incidence, Outcomes and Risk Factors of Heparin-Induced Thrombocytopenia After Total Joint Arthroplasty: A National Inpatient Sample Database Study
title_sort incidence, outcomes and risk factors of heparin-induced thrombocytopenia after total joint arthroplasty: a national inpatient sample database study
topic Original Manuscript
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495517/
https://www.ncbi.nlm.nih.gov/pubmed/34558329
http://dx.doi.org/10.1177/10760296211042938
work_keys_str_mv AT chenyuhang incidenceoutcomesandriskfactorsofheparininducedthrombocytopeniaaftertotaljointarthroplastyanationalinpatientsampledatabasestudy
AT wangjian incidenceoutcomesandriskfactorsofheparininducedthrombocytopeniaaftertotaljointarthroplastyanationalinpatientsampledatabasestudy
AT shizhanjun incidenceoutcomesandriskfactorsofheparininducedthrombocytopeniaaftertotaljointarthroplastyanationalinpatientsampledatabasestudy
AT zhangyang incidenceoutcomesandriskfactorsofheparininducedthrombocytopeniaaftertotaljointarthroplastyanationalinpatientsampledatabasestudy
AT yangqinfeng incidenceoutcomesandriskfactorsofheparininducedthrombocytopeniaaftertotaljointarthroplastyanationalinpatientsampledatabasestudy
AT xuyichuan incidenceoutcomesandriskfactorsofheparininducedthrombocytopeniaaftertotaljointarthroplastyanationalinpatientsampledatabasestudy